colorectal neoplasm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Colorectal neoplasms larger than 20 mm that were difficult to remove en bloc with conventional EMR 2 Colorectal neoplasms predicted to be non-invasive tumors and cancers with minute (less than 1000um) submucosal invasion
Exclusion criteria
Exclusion criteria: 1 residual lesions after EMR 2 patients with IBD or FAP 3 patients with hematological abnormality 4 patients with severe organ failure 5 patients who have been judged as in appropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ESD procedure time which is measured from the start of the submucosal injection until removal of the lesion | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-completion rate, R0 resection rate, adverse events | — |
Countries
Japan
Contacts
Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Gastrointestinal Oncology